drugset / Trial / NCT04400916

Topical Tranexamic Acid After Intravitreal Injections

NCT04400916 ↗

Unknown 100 enrolled Rambam Health Care Campus
RandomizedParallel-groupSingle-blindPrevention

Summary

We aim to investigate whether topical administration of Tranexamic acid can reduce the occurence of subconjunctival hemorrahge after routine intravitreal injections for retinal conditions.

Timeline

Start
2020-09
Primary completion
2021-09
Completion
2021-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule — Topical

Indications